Drug Delivery Markets: Oral Delivery

826 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
826
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Drug Delivery Markets: Oral Delivery

  1. 1. Get more info on this report!Drug Delivery Markets: Oral DeliveryJuly 1, 2009Since our last edition of this report in 2007, the oral drug delivery market is the largestsegment of the drug delivery market, and there’s no sign that it is slowing down. Withpharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderlypopulation that requires products with a level of ease-of-use and cost benefit, it’s nosurprise that the oral drug delivery market is a $35 billion industry and expected to growas much as ten percent per year.Kalorama’s Drug Delivery Markets: Oral Delivery provides the definitive break down ofthe market for oral delivery drug markets. The report covers both the major technologiesin oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked andmicroemulsion formulations) and the products that use these delivery technologies.In the reporting of market size and growth through 2013, Kalorama’s unique analysisbreaks out separates the value of the technology portion of the market from theactive ingriedient portion of the market, allowing for a deeper understanding of the valueof the market attributable to the delivery technologies themselves.This focused report provides information on the revenues for relevant companies andprovides information critical to assessing the opportunities available in this market,including: Legacy Companies in Oral Delivery as well as Recent Entrants Current World Wide Revenue Across Product Categories and Future Forecasts Revenues by Combonent and by Component ( Pharmaceutical vs. Technology portion of Revenue) Type of Delivery (Timed Release vs. Other) Challenges Faced by Oral-Delivery Technology Companies Success Stories and Pitfalls The Trends That are Expected to Lead to Global GrowthKalorama’s trusted information-gathering process provides most accurate study of theoral delivery drug market available today. Information and analysis presented in thisreport is based on extensive interviews with senior management of top companies in
  2. 2. the industry. While major research literature and government information is culled,information is corroborated and key market insights originate from interviews withindustry leaders.Product managers, marketing managers, business development executives, advertisingagency or investment firm executives, and information and research center librariansare among the individuals who will find this report on the oral delivery drug marketessential.Additional InformationNew York, July 14, 2009 — The worldwide market for oral drugs using drug deliverytechnologies has experienced tremendous growth over the last few years according toDrug Delivery Markets: Oral Delivery, a new report from Kalorama Information, aleading publisher in the life sciences research market, a trajectory that is projected togain momentum through 2013 as other pharmaceutical product areas are challenged.In 2008, the oral drug delivery market reached revenues at the manufacturer’s level of$43 billion for both major technologies in oral delivery and the products that use thesedelivery technologies. Kalorama forecasts the market will reach $71 billion by 2013, witha compound annual growth rate (CAGR) of almost 11% for the five-year periodbeginning in 2009.Over the next few years, Kalorama projects consolidation will increasingly impact themarket as funding from big companies leads to better products and more research anddevelopment. Large pharmaceutical companies are expected to continue acquiring drugdelivery companies to expand their presence, deepen product lines, and createpotential extensions for existing products; while larger drug delivery companies willcontinue to acquire smaller start-up companies to broaden their drug delivery platforms.“Those products with enhanced delivery technologies have a better chance of meetingeconomic and patent challenges near-term,” says Bruce Carlson, publisher of KaloramaInformation. “That’s why we will see drug delivery companies become more involvedearlier in the research and development process. Higher-quality products withexceptional drug delivery methods will encourage patient compliance and innovativediscoveries.”Additional market drivers include growth in the elderly population, patent issues amonglarge pharmaceutical companies, differentiation of existing and future products by drugdelivery mechanism, population growth, and new developments in drug delivery that areboth fueling growth in the pharmaceutical market and providing opportunities to extendproduct lifecycles.
  3. 3. Drug Delivery Markets: Oral Delivery provides the definitive breakdown of the globaloral drug delivery market. The report covers both the major technologies in oral delivery(controlled-release, delayed release, pulsatile-release, taste-masked and microemulsionformulations) and the products that use these delivery technologies. Included aremarket size and growth through 2013, in addition to information critical to assessing theopportunities available in the market.About Kalorama InformationKalorama Information supplies the latest in independent market research in the lifesciences, as well as a full range of custom research services.TABLE OF CONTENTSChapter One: Executive Summary Market Drivers Market Size and Growth o Total Oral Drug Delivery Market o Oral Drug Delivery Technology Only Market Competitive and Market AnalysisChapter Two: Introduction and Overview Scope of the Report Methodology History of Oral Drug Delivery Phases of Drug Action Barriers to Oral Drug Delivery Controlled-Release/Sustained-Release Delayed Release and Modified Release Fast Dissolving Taste-Masked Pulsatile Release Microemulsion and OthersChapter Three: Key Trends and Demographics The Elderly Regulatory Environment Patent Protection and Extension Earlier Involvement
  4. 4. Consolidation Proprietary Product Development Implications for Generic and Over-the-Counter Products Pharmaceutical FormulationChapter Four: New Developments Macromolecule Delivery Delivery of Hydrophobic Drugs Other Delivery SolutionsChapter Five: Market Size and Growth The Total Oral Drug Delivery Market Oral Delivery Technology Only MarketChapter Six: Competitive Analysis Competitive LandscapeChapter Seven: Company Profiles ALZA Corporation Biovail Corporation Elan Corporation, plc Emisphere Technologies, Inc. Ethypharm KV Pharmaceutical Labopharm, Inc. Penwest Pharmaceutical Company Purdue/MundiPharma/Napp Group SkyePharma PLC Watson Pharmaceuticals, Inc.Chapte Eight: Companies in Brief Alkermes, Inc. Astellas Pharma US CIMA Labs, Inc. Division of Cephalon DepoMed, Inc. Eurand, Inc. Galenix Intelgenx Technologies Corp Kos Pharmaceuticals, Inc. Lifecycle Pharma MicroDose Therapeutics, Inc. Scolr Pharma
  5. 5. XcelienceAppendix: Company DirectoryList of ExhibitsChapter One: Executive Summary Chapter Two: Introduction and Overview Table 2-1: Selected Types of Oral Solid Preparations Table 2-2: Sequence of Drug ActionChapter Three: Key Trends and Demographics Table 3-1: World Population by Age Group 2006-2013 Figure 3-1: World Population by Age Group 2006-2013 Table 3-2: Recent Consolidations in the Drug Delivery MarketChapter Four: New DevelopmentsChapter Five: Market Size and Growth Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2006-2013 Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2006-2013 Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013 Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013 Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2006-2013 Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2006-2013 Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Delivery Technology Components 2006-2013 Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical vs. Delivery Technology Component 2006, 2010Chapter Six: Competitive Analysis Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)
  6. 6. Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2290102US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004

×